Abstract Topics

Late Breaking Abstract Submission is open
November 28, 2022 – January 23, 2023 23:59 EDT.

Submit Abstract

Basic Science

  • Taxonomy
  • Animal Models and Papillomaviruses
  • Immunology
  • Regulation of Gene Expression, Post-transcriptional Modification
  • Transformation and Carcinogenesis
  • Structural Biology
  • Virus – Host Interactions
  • Virus Life Cycle
  • Genomics of HPV-Associated Disease
  • Papillomavirus Vaccines (i.e New Developments)
  • Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
  • Microbiome
  • Other Basic Research

Clinical Research

  • Self-Sampling and the Other New Technologies for Cervical Screening
  • HPV Diagnostics and Biomarkers for Early Detection and Management of Cervical Cancer and Related Precursors
  • Diagnosis and Management of HPV-Related Anogenital Cancers Other Than Cervix: Penile, Vaginal, Vulvar and Urological Cancer and Related Precursors
  • Behavioral Science Aspects of New Technologies in Cervical Screening Including Dissemination/Communication Research
  • Diagnosis and Management of Anal Cancer and Related Precursors: Screening, Diagnosis and Management
  • Diagnosis and Management of HPV-Related Oropharyngeal, Head and Neck Cancer
  • Diagnosis and Management of Genital and Cutaneous Warts
  • Diagnosis and Management of Cutaneous Warts and Other Skin Lesions
  • Prophylactic Vaccines – Clinical Aspects
  • Therapeutic Vaccines – Clinical Aspects
  • Diagnosis and Management of HPV Disease in People Living with HIV and Other Forms of Immunocompromise
  • Screening, Diagnosis and Treatment of Cervical Precancer in Low-Resource Settings
  • Novel Therapeutic Approaches to Treatment of HPV-Related Disease Including Antivirals
  • Novel Diagnostic Technologies for HPV-Related Disease
  • Recurrent Respiratory Papillomatosis
  • HPV NAAT Screening Quality Control/Assurance Guidelines
  • Other Clinical Research

Public Health, Epidemiology and Implementation Science

  • Global Impact of HPV and Cervical Cancer Prevention
  • Epidemiology: Natural History/Risk Factors (Cervix)
  • Epidemiology: Natural History/Risk Factors (Anal)
  • Screening for HPV-Related Disease: Implementation, Evaluation and Impact
  • Vaccination: Implementation, Evaluation and Impact
  • Economics and Mathematical Modelling
  • Cervical Cancer Elimination
  • Vaccine Safety
  • Impacts of COVID-19 Pandemic on HPV Vaccination Implementation
  • Impacts of COVID-19 Pandemic on Public Health Aspects of HPV Screening
  • Other Public Health, Epidemiology and Implementation Science Research
Visit 2021 website Membership